15165 - ISTH "Diagnosis and Treatment of Rare Coagulation Bleeding Disorders"

Sam SchulmanThe Coagulation Cascade

The coagulation cascade is not an isolated phenomenon but takes place on phospholipid bilayers of cell surfaces. It is also an interplay with microparticles, natural inhibitors vascular walls and the inflammatory system.

Diane Nugent - Coagulation Disorders

Rare clotting disorders go undiagnosed for years and present a challenge for the busy practitioner as the pathway to final diagnosis requires time to take a thorough family and personal history, as well as a local reference laboratory with capability to go beyond baseline coagulation screen.  This presentation will cover some of the signs and symptoms of the more "common" rare disorders, and provide information on specific diagnostic and therapeutic options. 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and International Society on Thrombosis and Haemostasis. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 
Designation of Credit Statement:
The Medical College of Wisconsin designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Please note: The course fee is $25.00 in addition to a $2.50 processing fee which is assessed for all electronic registrations.
 
More information and online registration:  http://www.prolibraries.com/isth/
 
 
This meeting is supported by an unrestricted educational grant from Instrumentation Laboratory
 

Target Audience

Medical student, residents, lab technologists, thrombosis nurses, hemophilia nurses

Learning Objectives

At the conclusion of this activity, I will be able to:

  • Understand the principles of clot generation on cell-based phospholipid surfaces
  • Examine the interplay of coagulation mechanisms with natural inhibitors as well as the inflammation system
Additional information

CME Coordinator Contact Information

Name: 
Cary Clark
Phone Number: 
+1 (919) 929-3807
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
10/21/2015
Course expires: 
10/21/2016
Cost:
$2.50
Planning Committee:
Yukio Ozaki
Geoff Barnes
Chris Ward
Cary Clark
Stephen Watson
 
Speakers:
Sam Schulman - "Coagulation Cascade"
Diane Nugent - "Coagulation Disorders"
 
 
Moderator:
Vinai Bhagirath
 
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following persons:  
 

Name

Company

Role

Chris Ward, MD

Bayer

Advisory Board, Speaker

Pfizer, BMS

Advisory Board, Speaker

Boehringer-Ingelheim

Advisory Board, Speaker

Alexion

Advisory Board

Medimark

Steering Committee Member, Speaker

Geoff Barnes

BMS, Pfizer, Blue Cross Blue Shield of Michigan

Primary Investigator & Co-Investigator

Yukio Ozaki

Sysmex

Advisory Board

Sam SchulmanBoehringer IngelheimSpeaker, Advisor, PI
 OctapharmaPI
 BaxterPI


In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
10/21/2015
Course expires: 
10/21/2016

Price

Cost:
$2.50
Please login or register to take this course.

Required Hardware/software

To view the webcast on your computer go to https://www.isth.org/  click the Events/Webinars tab and view the ISTH 2015 Archived Webinars

Participant%20Privacy.pdf